vTv Therapeutics Inc. Class A Common Stock is a biopharmaceutical company. Its innovative therapies aim to treat chronic diseases like Alzheimer’s and diabetes. Their drugs are based on groundbreaking science and have shown promising results in clinical trials. With a strong focus on research and development, vTv Therapeutics is committed to improving patient outcomes and transforming the healthcare industry.
